Sinopharm Group Co (FRA:X2S) Total Stockholders Equity : €9,674 Mil (As of Jun. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Sinopharm Group Co Total Stockholders Equity?

Sinopharm Group Co's Total Stockholders Equity for the quarter that ended in Jun. 2024 was €9,674 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Sinopharm Group Co's Book Value per Share for the quarter that ended in Jun. 2024 was €3.10. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Sinopharm Group Co's Debt-to-Equity for the quarter that ended in Jun. 2024 was 1.34.

Sinopharm Group Co Total Stockholders Equity Historical Data

The historical data trend for Sinopharm Group Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinopharm Group Co Total Stockholders Equity Chart

Sinopharm Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

6,085.22

7,084.39

8,598.92

9,216.79

9,578.43

Sinopharm Group Co Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Total Stockholders Equity	Get a 7-Day Free Trial															8,935.64	9,216.79	8,971.01	9,578.43	9,673.52

Sinopharm Group Co (FRA:X2S) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Sinopharm Group Co's Book Value per Share for the quarter that ended in Jun. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(9673.519	-	0)	/	3120.66
	=	3.10

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Sinopharm Group Co's Debt-to-Equity for the quarter that ended in Jun. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(10430.017	+	2510.602)	/	9673.519
	=	1.34

Sinopharm Group Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Sinopharm Group Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinopharm Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sinopharm Group Co Ltd (FRA:X2S) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

SHTDY:USA SHTDF:USA 01099:Hong Kong X2S1:Germany X2S:Germany

Address

No. 385, East Longhua Road, Sinopharm Group Building, Huangpu District, Shanghai, CHN, 200023

Website

http://www.sinopharmgroup.com.cn

Founded in 2003, Sinopharm is the largest wholesaler and retailer of drugs and medical devices in China and listed on the Hong Kong Stock Exchange in 2009. It is a core subsidiary of China National Pharmaceutical Group. Sinopharm's largest operating segment is pharmaceutical distribution, making up over 70% of its total revenue by the end of 2023. In 2018, Sinopharm acquired the largest Chinese medical device distributor, China National Scientific Instruments and Materials. Now, medical device distribution accounts for over 20% of Sinopharm's total revenue. Sinopharm's downstream customers range from hospitals and other health services institutions to end-customers.

Sinopharm Group Co Headlines

No Headlines